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Brief Communications
West Nile virus infection in reindeer (Rangifer tarandus)
Mitchell V. Palmer1, William C. Stoffregen, Douglas G. Rogers, Amir N. Hamir, Juergen A. Richt,
Douglas D. Pedersen, W. Ray Waters
Abstract. West Nile virus (WNV) infection in 4 reindeer (Rangifer tarandus) resulted in lymphohistiocytic
encephalomyelitis within the medulla oblongata and cervical spinal cord. Immunohistochemistry revealed WNV
antigen within neurons and among mononuclear cell infiltrates. These represent the first known cases of clinical
WNV infection in Cervidae. Clinical signs and lesions were similar to those described in horses. Nucleotide
sequence of a 768-bp region of the WNV E-glycoprotein gene revealed 1 nucleotide mutation, which resulted
in a single amino acid substitution from a serine to a glycine (position 227 of E-glycoprotein) when compared
with the prototype WNV-NY99 strain (isolated from Bronx zoo flamingo 382-99).
West Nile virus (WNV) is a member of the Flaviviridae
family (genus Flavivirus), isolated originally from the blood
of a febrile human in Uganda in 1937.15 Mosquito vectors
transmit the virus among reservoir bird populations, and sus-
ceptible mammalian species are infected incidentally. Ideal
conditions for the propagation of WNV transmission include
1) a viremic host bird, 2) active ornithophilic mosquito vec-
tors, and 3) large numbers of amplifying avian host species.13
Infection of incidental hosts can result in a variety of host–
pathogen responses ranging from subclinical to severe neu-
rological disease with encephalitis and death.7 West Nile vi-
rus is 1 of the most geographically widespread flaviviruses
and is related to Japanese encephalitis virus, Kunjin virus,
and St. Louis encephalitis virus. The virus was first detected
in North America in the summer of 1999 in the New York
City metropolitan area, during an epizootic involving birds,
horses, and humans. Each summer and fall since 1999, the
geographic range of WNV in North America has continued
to expand westward.12 The WNV isolate responsible for the
initial epizootic in North America is genetically similar to
an isolate recovered from the brain of a dead goose in Israel
in 1998.9
In outbreaks since the mid-1990s, several epidemiological
trends for WNV infections have been observed that include
1) increased frequency of occurrence in humans and horses,
2) apparent increase in severe clinical disease in humans,
and 3) high avian death rates accompanying the human out-
breaks, especially in the United States and Israel.12 The range
of susceptible host species has also increased to include nu-
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merous wildlife species.10 The purpose of this report is to
describe WNV infection with concurrent neurological dis-
ease in reindeer and to describe the lesions associated with
WNV infection in reindeer.
Reindeer 1, 2, and 3 were housed with 17 other reindeer
at the National Animal Disease Center (NADC), Ames,
Iowa. The reindeer had originated from a farm in southern
Michigan and had been shipped as a group to Ames in May
2002 for use as noninfected controls in tuberculosis diag-
nosis research. Upon arrival, reindeer had been dewormed
with ivermectina and vaccinated with a multivalent clostrid-
ial bacterin.b Reindeer 4 was a 5-year-old male, 1 of several
reindeer in a wildlife park in eastern Nebraska.
In September 2002, 4 months after arrival, over a 7-day
period, reindeer 1, 2, and 3 exhibited similar clinical signs
before death. All were adult males, ranging in age from 2
to 4 years. Reindeer 1 and 2 were found in lateral recum-
bency, unable to rise to sternal recumbency, even with as-
sistance. Both animals were febrile (40 C) and exhibited
paddling of all 4 limbs. Both animals were euthanized by
IV sodium pentobarbital. Reindeer 1 had a history of diar-
rhea of 1–2 weeks duration before death. Reindeer 3 was
first observed separated from the remainder of the herd, de-
pressed, head tilt to the left, flaccid tongue, dysphagic with
difficulty in drinking, and febrile (40 C). Treatment consisted
of dexamethasone (20 mg), flunixin meglumine (1.1 mg/kg),
and IV fluids. Within 12 hours, the animal’s condition had
progressed to lateral recumbency and paddling similar to that
observed in the first 2 reindeer, at which time the deer was
euthanized as described above. Reindeer 4 was clinically
normal and grazing the previous day but was found dead the
next morning.
All reindeer were in good physical condition. Normal-ap-
pearing forage was present in the forestomachs of all ani-
mals. There were no gross lesions in any of the reindeer.
Brain was collected from reindeer 1 and immersed in neutral
10% buffered formalin. The following tissues were collected
for histopathology from reindeer 2, 3, and 4: tongue, tonsil,
salivary gland, eye, brain, myocardium, lung, cervical and
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Figure 1. Photomicrograph of section of brain from reindeer 3.
Note perivascular infiltrates of mononuclear inflammatory cells. Bar
5 150 mm. HE.
Figure 2. Photomicrograph of section of brain from reindeer 3.
Note shrunken degenerate neuron surrounded by mononuclear in-
flammatory cells. Bar 5 50 mm. HE.
Figure 3. Photomicrograph of section of brain from reindeer 3,
A, and 4, B. Note amorphous immunohistochemical staining within
focus of inflammatory cells, A, as well as intraneuronal staining, B.
Bar 5 50 mm. Immunoperoxidase method, hematoxylin counter-
stain, A, alkaline phosphatase method, hematoxylin counterstain, B.
thoracic spinal cord, abomasum, rumen, small intestine, mes-
enteric lymph node, spleen, liver, adrenal gland, kidney, co-
lon, urinary bladder, and skeletal muscle. Tissue specimens
were immersed in 10% neutral buffered formalin, processed
routinely, embedded in paraffin, sectioned at 4 mm, and
stained with hematoxylin and eosin (HE). Microscopic le-
sions in nervous tissue from all 4 reindeer were classified as
mild to moderate and confined primarily to the medulla ob-
longata, cerebellum, and cervical spinal cord. In sections of
medulla oblongata, cerebellum, and spinal cord, blood ves-
sels in the pia mater and scattered blood vessels in the neu-
ropil were surrounded by variable numbers of mononuclear
cells (Fig. 1) and occasional neutrophils. Infiltrates of small
numbers of mononuclear cells and neutrophils were present
in the neuropil adjacent to vessels. Scattered neurons were
hypereosinophilic with a granular appearance or had under-
gone necrosis with neuronophagia present (Fig. 2). Multiple
small foci of gliosis and microgliosis were also noted. Sec-
tions of kidney from reindeer 2, 3, and 4 were characterized
by mild multifocal lymphoplasmacytic interstitial nephritis,
and small numbers of proteinaceous and mineralized casts
were present within collecting ducts. No significant micro-
scopic lesions were seen in other tissue specimens examined
from any of the reindeer.
Formalin-fixed, paraffin-embedded sections of brain, spi-
nal cord, and other tissues were mounted on poly-L-lysine–
coated slides for immunohistochemical (IHC) labeling of
WNV antigen using anti-WNV primary antibody.c An iso-
type-matched mouse antibody was substituted in the proce-
dure to serve as a negative control. Brain from a WNV-
infected bird was used as positive control tissue. Immuno-
histochemistry identified WNV antigen in the cytoplasm of
few neurons in the medulla oblongata and cervical spinal
cord. Positive immunohistochemical reactivity was also pre-
sent in foci of mononuclear cell infiltrates within the medulla
oblongata and spinal cord (Fig. 3). The intensity of staining
varied from section to section but was typically mild. Inter-
estingly, positive immunohistochemical staining for WNV
antigen was not seen in other tissues.
Samples of brain from reindeer 2 and 3 were also collected
and submitted for bacteriologic isolation. Samples of brain-
stem and cerebellum were submitted for molecular diagnosis
of WNV infection by reverse transcriptase–PCR (RT-PCR)
using selected primers that amplified a portion of the highly
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conserved E region of the genome of the WNV identified as
NY99.8 No bacterial pathogens were isolated; however, brain
specimens were positive for WNV by RT-PCR. Viral RNA
was extracted from cerebrospinal fluid (CSF) collected from
reindeer 3 and analyzed by RT-PCR using primers EDL/E-
U14763 and EDL/E-L25383 (specific for the WNV E-glyco-
protein gene). A second round of seminested PCR was done
using primers EDL/E-U14763 and EDL/E-L2244.3 A 768-bp
fragment generated using seminested PCR was sequenced and
shown to differ by 1 bp from the sequence of prototype
NY99. This difference results in 1 amino acid substitution
from a serine to a glycine (position 227 of E-glycoprotein)
when compared with the prototype WNV-NY99 strain (iso-
lated from Bronx zoo flamingo 382-99).9
Blood was collected from all NADC reindeer approximate-
ly 3 months before the death of reindeer 1, 2, and 3; from
reindeer 2 and 3 immediately before euthanasia; and from the
remaining NADC reindeer approximately 3 days after the
death of reindeer 1, 2, and 3. Blood was also collected from
10 captive white-tailed deer (Odocoileus virginianus) in a
nearby pasture at approximately the same time points that
blood was collected from the reindeer. Antibody titers to
WNV were determined using the plaque-reduction neutrali-
zation test (PRNT) as described previously.11 Plaque reduction
of $90% was recorded as positive. A PRNT titer of $1:10
was considered significant. Blood samples collected from all
NADC reindeer including reindeer 1, 2, and 3 approximately
3 months before euthanasia were negative (1:10 serum dilu-
tion showing plaque reduction of ,90%) for antibodies to
WNV. Antibody titers to WNV in sera from reindeer 2 and 3
just before euthanasia were $1:100 (1:100 serum dilution
showing $90% plaque reduction). Of the remaining reindeer
that did not demonstrate clinical signs of WNV infection, 9
of 17 (53%) also developed antibody titers of $1:100 and 6
of 10 (60%) captive white-tailed deer sampled from a nearby
pasture showed similar seroconversion from negative to pos-
itive ($1:100) during a similar time period.
Cerebrospinal fluid was collected from reindeer 3 at the
time of necropsy. Whole blood was collected in potassium
ethylenediaminetetraacetic acid for complete blood counts.
Results were compared with reference intervals that were
determined previously for this group of reindeer at NADC.
Examination of blood from reindeer 2 and 3 revealed leu-
kocytosis with a mature neutrophilia and lymphopenia. El-
evated fibrinogen was noted in reindeer 2. Examination of
CSF from reindeer 3 revealed a lymphocytic pleocytosis
composed primarily of small- and medium-sized lympho-
cytes.
The criteria for a clinical diagnosis of encephalitis caused
by WNV in horses must include 1 or more of the following
clinical signs: ataxia (stumbling, staggering, wobbly gait, or
uncoordination), inability to stand, multiple limb paralysis,
or death.11 Clinical signs must also be accompanied by 1 or
more of the following diagnostic criteria: isolation of WNV
from tissue, blood, or CSF; 4-fold or greater change in an-
tibody titer to WNV in paired sera; or an elevated titer to
WNV in a single serum sample.11 Probable cases are defined
as those where clinical signs are accompanied by the detec-
tion of WNV antigen in tissue by IHC.11 According to these
definitions, 2 reindeer in this report are confirmed WNV in-
fections, and 2 reindeer are probable WNV infections.
To the authors’ knowledge, this represents the first de-
scription of WNV infection in reindeer. The clinical signs
seen in reindeer infected with WNV in this report, included
fever, depression, head tilt, and recumbency, similar to clin-
ical signs seen in horses infected with WNV.5,11 Moreover,
these cases were observed in September–October 2002, a
season similar to the peak in clinical equine cases reported
in the eastern United States in 2000.5,11 This similarity is
likely the result of both vector activity and a similar incu-
bation period for reindeer and horses.
Microscopic lesions in affected reindeer are similar to
those seen in naturally infected horses5 and in experimentally
infected hamsters (Mesocricetus auratus).18 Lesions in hors-
es are described as mild to moderate lymphocytic or histio-
cytic encephalomyelitis with focal gliosis, perivascular cuff-
ing of mononuclear cells, neuronal degeneration, neurono-
phagia, and petechial hemorrhages.5 Lesions in horses are
primarily confined to the lower brain stem and spinal cord.
Degenerative and necrotic changes to neurons have been at-
tributed to apoptosis.16,18 Lesions generally are not seen in
other organs.
With the exception of viruses that induce hemorrhagic dis-
ease, clinical signs from arboviral infections are rare in Cer-
vidae, although serologic evidence of exposure to western
equine encephalitis virus, California encephalitis virus, Ve-
nezuelan equine encephalitis virus, and St. Louis encepha-
litis virus has been reported.17 As this report demonstrates,
the mammalian host range for WNV is not completely de-
fined. Encephalitis caused by naturally occurring WNV in-
fection has been reported in horses5,6 and man.4 Experimental
WNV infection results in encephalitis in mice and rhesus
monkeys (Macaca mulatta).15 However, mammals such as
dogs, rabbits, guinea pigs (Covia porceius), and hedgehogs
(Erinaceus europaeus) do not develop encephalitis after ex-
perimental inoculation with WNV.2,15 Experimental infection
of sheep with WNV does not result in clinical signs; how-
ever, neonatal death and hydranencephaly may be seen in
lambs of ewes infected experimentally before conception or
during gestation.1
Diagnosis of natural WNV encephalitis in reindeer 2 and
3 is on the basis of seroconversion and the presence of
WNV-specific nucleic acid in the brain and CSF. Reverse
transcriptase–PCR amplification was positive with brain tis-
sue and CSF using different primer sets targeting the E-
glycoprotein gene. Nucleotide and deduced amino acid se-
quence revealed 1 nucleotide mutation within the amplifi-
cation product of 768 bp, which resulted in an amino acid
substitution from a serine to a glycine (position 227 of E-
glycoprotein) when compared with the prototype WNV-
NY99 strain (isolated from Bronx zoo flamingo 382-99).9
All other North American WNV isolates have a serine res-
idue at position 227 of the E-glycoprotein, and mutations at
this position have been found previously in 2 WNV isolates
from India with substitutions from serine to asparagine (Cu-
lex WNV isolate G22886; GenBank AF196524) and serine
to threonine (human WNV isolate; GenBank AF196524).14
Whether mutation within this region of the E-glycoprotein
is a result of an immune evasion mechanism or the adapta-
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tion of the WNV to the reindeer host is not known at present.
A phylogenetic tree based on the E-gene nucleic acid se-
quence data from prototype WNV lineage I and II viruses
and known North American WNV isolates was constructed.
The WNV reindeer isolate grouped within WNV lineage I
together with North American and Israeli WNV isolates
(data not shown).
Although not specific for WNV infection, leukogram
changes in affected reindeer were consistent with a stress
leukogram and suggestive of a viral infection. This is in
contrast to dogs infected experimentally with WNV and
horses naturally infected with WNV where, in the latter spe-
cies, no detectable changes in hemogram or leukogram are
seen.2,5
As the geographic range of WNV expands, prevention and
control measures become increasingly important. Current
recommendations for the prevention of WNV infection in
horses include reducing sources of standing water essential
for mosquito breeding and decreasing exposure to mosquito
bites.11 Although a killed virus vaccine is commercially
available and licensed for use in horses, it is not currently
licensed for use in reindeer. However, recommendations re-
garding the elimination of mosquito-breeding sites and re-
ducing exposure to mosquito bites are warranted for rein-
deer.
Reindeer may be more susceptible than other species of
Cervidae to WNV because adjacent or near the pastures,
where 3 of the 4 reindeer in the current report were kept, 30
elk (Cervus elaphus) and 40 white-tailed deer were located.
No clinical signs suggestive of WNV infection were seen in
either elk or white-tailed deer during this period, although a
subgroup (n 5 10) of these white-tailed deer showed a sim-
ilar seroconversion to WNV as that seen in the reindeer.
Additionally, sheep, bison (Bison bison), horses, and cattle
located near the reindeer pasture did not show clinical signs
suggestive of WNV infection.
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